메뉴 건너뛰기




Volumn 204, Issue 12, 2011, Pages 1839-1842

Hepatitis C transmission in injection drug users: Could swabs be the main culprit?

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

EID: 81055124993     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir650     Document Type: Article
Times cited : (20)

References (16)
  • 1
    • 33747026928 scopus 로고    scopus 로고
    • Impact of a harm-reduction policy on HIV and hepatitis C virus transmission among drug users: Recent French data - The ANRS-Coquelicot study
    • DOI 10.1080/10826080600847951, PII W461677756681022
    • Jauffret-Roustide M, Emmanuelli J, Quaglia M, et al. Impact of a harmreduction policy on HIV and hepatitis C virus transmission among drug users: recent French datadthe ANRS-Coquelicot Study. Subst Use Misuse 2006; 41:1603-21. (Pubitemid 44470232)
    • (2006) Substance Use and Misuse , vol.41 , Issue.10-12 , pp. 1603-1621
    • Jauffret-Roustide, M.1    Emmanuelli, J.2    Quaglia, M.3    Barin, F.4    Arduin, P.5    Laporte, A.6    Desenclos, J.-C.7
  • 2
    • 77956930839 scopus 로고    scopus 로고
    • Survival of hepatitis C virus in syringes: Implication for transmission among injection drug users
    • Paintsil E, He H, Peters C, Lindenbach BD, Heimer R. Survival of hepatitis C virus in syringes: implication for transmission among injection drug users. J Infect Dis 2010; 202:984-90.
    • (2010) J Infect Dis , vol.202 , pp. 984-990
    • Paintsil, E.1    He, H.2    Peters, C.3    Lindenbach, B.D.4    Heimer, R.5
  • 3
    • 77952572492 scopus 로고    scopus 로고
    • How stable is the hepatitis C virus (HCV)? Environmental stability of HCV and its susceptibility to chemical biocides
    • Ciesek S, Friesland M, Steinmann J, et al. How stable is the hepatitis C virus (HCV)? Environmental stability of HCV and its susceptibility to chemical biocides. J Infect Dis 2010; 201:1859-66.
    • (2010) J Infect Dis , vol.201 , pp. 1859-1866
    • Ciesek, S.1    Friesland, M.2    Steinmann, J.3
  • 4
    • 78549236194 scopus 로고    scopus 로고
    • The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: A systematic review
    • Gillies M, Palmateer N, Hutchinson S, Ahmed S, Taylor A, Goldberg D. The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review. BMC Public Health 2010; 10:721.
    • (2010) BMC Public Health , vol.10 , pp. 721
    • Gillies, M.1    Palmateer, N.2    Hutchinson, S.3    Ahmed, S.4    Taylor, A.5    Goldberg, D.6
  • 5
    • 79751471357 scopus 로고    scopus 로고
    • Changes in blood-borne infection risk among injection drug users
    • Mehta SH, Astemborski J, Kirk GD, et al. Changes in blood-borne infection risk among injection drug users. J Infect Dis 2011; 203: 587-94.
    • (2011) J Infect Dis , vol.203 , pp. 587-594
    • Mehta, S.H.1    Astemborski, J.2    Kirk, G.D.3
  • 6
    • 77950661287 scopus 로고    scopus 로고
    • Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: A review of reviews
    • Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction 2010; 105:844-59.
    • (2010) Addiction , vol.105 , pp. 844-859
    • Palmateer, N.1    Kimber, J.2    Hickman, M.3    Hutchinson, S.4    Rhodes, T.5    Goldberg, D.6
  • 7
    • 33746257676 scopus 로고    scopus 로고
    • Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users
    • DOI 10.1111/j.1365-2893.2006.00725.x
    • Mathei C, Shkedy Z, Denis B, et al. Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users. J Viral Hepat 2006; 13:560-70. (Pubitemid 44100408)
    • (2006) Journal of Viral Hepatitis , vol.13 , Issue.8 , pp. 560-570
    • Mathei, C.1    Shkedy, Z.2    Denis, B.3    Kabali, C.4    Aerts, M.5    Molenberghs, G.6    Van Damme, P.7    Buntinx, F.8
  • 8
    • 38849143148 scopus 로고    scopus 로고
    • Broadening discussions of "safe" in hepatitis C prevention: A close-up of swabbing in an analysis of video recordings of injecting practice
    • DOI 10.1016/j.drugpo.2007.01.005, PII S0955395907000060
    • Treloar C, Laybutt B, Jauncey M, et al. Broadening discussions of "safe" in hepatitis C prevention: a close-up of swabbing in an analysis of video recordings of injecting practice. Int J Drug Policy 2008; 19:59-65. (Pubitemid 351200020)
    • (2008) International Journal of Drug Policy , vol.19 , Issue.1 , pp. 59-65
    • Treloar, C.1    Laybutt, B.2    Jauncey, M.3    Van Beek, I.4    Lodge, M.5    Malpas, G.6    Carruthers, S.7
  • 9
    • 0034619080 scopus 로고    scopus 로고
    • Minimising harm from hepatitis C virus needs better strategies
    • Crofts N, Caruana S, Bowden S, Kerger M. Minimising harm from hepatitis C virus needs better strategies. BMJ 2000; 321:899.
    • (2000) BMJ , vol.321 , pp. 899
    • Crofts, N.1    Caruana, S.2    Bowden, S.3    Kerger, M.4
  • 10
    • 79851514111 scopus 로고    scopus 로고
    • Comparable performance of TMA and real-time PCR in detecting minimal residual hepatitis C viraemia at the end of antiviral therapy
    • Bortoletto G, Campagnolo D, Mirandola S, et al. Comparable performance of TMA and real-time PCR in detecting minimal residual hepatitis C viraemia at the end of antiviral therapy. J Clin Virol 2011; 50:217-220.
    • (2011) J Clin Virol , vol.50 , pp. 217-220
    • Bortoletto, G.1    Campagnolo, D.2    Mirandola, S.3
  • 11
    • 69949099265 scopus 로고    scopus 로고
    • Evaluation of the Abbott investigational use only RealTime hepatitis C virus (HCV) assay and comparison to the Roche TaqMan HCV analyte-specific reagent assay
    • Pyne MT, Konnick EQ, Phansalkar A, Hillyard DR. Evaluation of the Abbott investigational use only RealTime hepatitis C virus (HCV) assay and comparison to the Roche TaqMan HCV analyte-specific reagent assay. J Clin Microbiol 2009; 47:2872-8.
    • (2009) J Clin Microbiol , vol.47 , pp. 2872-2878
    • Pyne, M.T.1    Konnick, E.Q.2    Phansalkar, A.3    Hillyard, D.R.4
  • 13
    • 54049119276 scopus 로고    scopus 로고
    • Initiators: An examination of young injecting drug users who initiate others to injecting
    • Bryant J, Treloar C. Initiators: an examination of young injecting drug users who initiate others to injecting. AIDS Behav 2008; 12: 885-90.
    • (2008) AIDS Behav , vol.12 , pp. 885-890
    • Bryant, J.1    Treloar, C.2
  • 14
    • 79957930147 scopus 로고    scopus 로고
    • A systematic review and metaanalysis of interventions to prevent hepatitis C virus infection in people who inject drugs
    • Hagan H, Pouget ER, Des Jarlais DC. A systematic review and metaanalysis of interventions to prevent hepatitis C virus infection in people who inject drugs. J Infect Dis 2011; 204:74-83.
    • (2011) J Infect Dis , vol.204 , pp. 74-83
    • Hagan, H.1    Pouget, E.R.2    Des Jarlais, D.C.3
  • 15
    • 77955697397 scopus 로고    scopus 로고
    • Estimation of illicit drugs consumption by wastewater analysis in Paris area (France)
    • Karolak S, Nefau T, Bailly E, Solgadi A, Levi Y. Estimation of illicit drugs consumption by wastewater analysis in Paris area (France). Forensic Sci Int 2010; 200:153-60.
    • (2010) Forensic Sci Int , vol.200 , pp. 153-160
    • Karolak, S.1    Nefau, T.2    Bailly, E.3    Solgadi, A.4    Levi, Y.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.